Hsu CH et al. |
Preparation and characterization of novel coenzyme Q10 nanoparticles engineered from microemulsion precursors. |
2003 |
AAPS PharmSciTech |
pmid:14621964
|
Nehilla BJ et al. |
Surfactant-free, drug-quantum-dot coloaded poly(lactide-co-glycolide) nanoparticles: towards multifunctional nanoparticles. |
2008 |
ACS Nano |
pmid:19206580
|
Shimizu H et al. |
Screening of detergents for solubilization, purification and crystallization of membrane proteins: a case study on succinate:ubiquinone oxidoreductase from Escherichia coli. |
2008 |
Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. |
pmid:18765923
|
Hasegawa G et al. |
Daily profile of plasma %CoQ10 level, a biomarker of oxidative stress, in patients with diabetes manifesting postprandial hyperglycaemia. |
2005 |
Acta Diabetol |
pmid:16382305
|
Wold LE et al. |
Insulin-like growth factor I (IGF-1) supplementation prevents diabetes-induced alterations in coenzymes Q9 and Q10. |
2003 |
Acta Diabetol |
pmid:12861406
|
Da Y et al. |
Successful treatment of periodic paralysis with coenzyme Q10: two case reports. |
2016 |
Acta Myol |
pmid:28344441
|
Grieb P et al. |
Oral coenzyme Q10 administration prevents the development of ischemic brain lesions in a rabbit model of symptomatic vasospasm. |
1997 |
Acta Neuropathol. |
pmid:9341938
|
Kernt M et al. |
Coenzyme Q10 prevents human lens epithelial cells from light-induced apoptotic cell death by reducing oxidative stress and stabilizing BAX / Bcl-2 ratio. |
2010 |
Acta Ophthalmol |
pmid:20374575
|
Fato R et al. |
Coenzyme Q10 vitreous levels after administration of coenzyme Q10 eyedrops in patients undergoing vitrectomy. |
2010 |
Acta Ophthalmol |
pmid:19799594
|
Kömürcü E et al. |
Preventive effects of coenzyme Q10 (CoQ10) on steroid-induced osteonecrosis in rats. |
2014 |
Acta Orthop Traumatol Turc |
pmid:24747633
|
Sato K |
Pharmacokinetics of coenzyme Q10 in recovery of acute sensorineural hearing loss due to hypoxia. |
1988 |
Acta Otolaryngol Suppl |
pmid:3245440
|
Guastini L et al. |
Water-soluble coenzyme Q10 formulation in presbycusis: long-term effects. |
2011 |
Acta Otolaryngol. |
pmid:21162656
|
Angeli SI et al. |
Coenzyme Q-10 treatment of patients with a 7445A--->G mitochondrial DNA mutation stops the progression of hearing loss. |
2005 |
Acta Otolaryngol. |
pmid:16092542
|
Hirose Y et al. |
Effect of water-soluble coenzyme Q10 on noise-induced hearing loss in guinea pigs. |
2008 |
Acta Otolaryngol. |
pmid:18607964
|
Fetoni AR et al. |
Efficacy of different routes of administration for Coenzyme Q10 formulation in noise-induced hearing loss: systemic versus transtympanic modality. |
2012 |
Acta Otolaryngol. |
pmid:22443854
|
Salami A et al. |
Water-soluble coenzyme Q10 formulation (Q-TER(®)) in the treatment of presbycusis. |
2010 |
Acta Otolaryngol. |
pmid:20443731
|
Sinniah D et al. |
Evaluation of the possible role of glucose, carnitine, coenzyme Q10 and steroids in the treatment of Reye's syndrome using the margosa oil animal model. |
1990 |
Acta Paediatr Jpn |
pmid:2288230
|
Korkm E et al. |
Development and evaluation of coenzyme Q10 loaded solid lipid nanoparticle hydrogel for enhanced dermal delivery. |
2013 |
Acta Pharm |
pmid:24451076
|
Okudan N et al. |
Effects of treatment with coenzyme Q10 on exercised rat aorta. |
2012 |
Acta Physiol Hung |
pmid:22425807
|
Piotrowska D et al. |
Antioxidative properties of coenzyme Q10 and vitamin E in exposure to xylene and gasoline and their mixture with methanol. |
2002 Nov-Dec |
Acta Pol Pharm |
pmid:12669764
|
Piotrowska D et al. |
Parameters of the oxidative stress in exposure to aromatic hydrocarbons and alcoholic derivatives and the influence of coenzyme Q10. |
2004 |
Acta Pol Pharm |
pmid:15909939
|
Sawicka E et al. |
The effects of coenzyme Q10 and baicalin in cisplatin-induced lipid peroxidation and nitrosative stress. |
2013 Nov-Dec |
Acta Pol Pharm |
pmid:24383321
|
Reid MS et al. |
A placebo-controlled screening trial of olanzapine, valproate, and coenzyme Q10/L-carnitine for the treatment of cocaine dependence. |
2005 |
Addiction |
pmid:15730349
|
Cusimano EM et al. |
Mitochondria: the hemi of the cell. |
2009 Jan-Mar |
Adv Emerg Nurs J |
pmid:20118854
|
Bresolin N et al. |
Immunological and biochemical studies and pilot therapeutic trial with ubidecarenone in Kearns-Sayre patients. |
1988 |
Adv Neurol |
pmid:3334786
|
Borek C |
Aging and antioxidants. Fruits and vegetables are powerful armor. |
2006 |
Adv Nurse Pract |
pmid:16471305
|
Marazzi G et al. |
Long-term effects of nutraceuticals (berberine, red yeast rice, policosanol) in elderly hypercholesterolemic patients. |
2011 |
Adv Ther |
pmid:22113535
|
Morin D et al. |
Mitochondria as target for antiischemic drugs. |
2001 |
Adv. Drug Deliv. Rev. |
pmid:11377809
|
Singh RB et al. |
Effect of taurine and coenzyme Q10 in patients with acute myocardial infarction. |
2003 |
Adv. Exp. Med. Biol. |
pmid:12908582
|
Damian MS |
Neuroprotection becomes reality: changing times for cerebral resuscitation. |
2004 |
Adv. Exp. Med. Biol. |
pmid:15053432
|
Artuch R et al. |
Coenzyme Q10 deficiencies in neuromuscular diseases. |
2009 |
Adv. Exp. Med. Biol. |
pmid:20225022
|
Keck M et al. |
Coenzyme Q10 does not enhance preadipocyte viability in an in vitro lipotransfer model. |
2012 |
Aesthetic Plast Surg |
pmid:21964747
|
Yubero-Serrano EM et al. |
Postprandial antioxidant effect of the Mediterranean diet supplemented with coenzyme Q10 in elderly men and women. |
2011 |
Age (Dordr) |
pmid:21170684
|
Yubero-Serrano EM et al. |
Postprandial antioxidant gene expression is modified by Mediterranean diet supplemented with coenzyme Q(10) in elderly men and women. |
2013 |
Age (Dordr) |
pmid:22057896
|
Shetty RA et al. |
Coenzyme Q(10) supplementation reverses age-related impairments in spatial learning and lowers protein oxidation. |
2013 |
Age (Dordr) |
pmid:23138632
|
Gutierrez-Mariscal FM et al. |
Mediterranean diet supplemented with coenzyme Q10 induces postprandial changes in p53 in response to oxidative DNA damage in elderly subjects. |
2012 |
Age (Dordr) |
pmid:21404051
|
Hof H |
Inability of ubiquinones to stimulate resistance of mice against infection with Listeria monocytogenes. |
1981 |
Agents Actions |
pmid:7257952
|
Park SK et al. |
Gene expression profiling of aging in multiple mouse strains: identification of aging biomarkers and impact of dietary antioxidants. |
2009 |
Aging Cell |
pmid:19555370
|
Ben-Meir A et al. |
Coenzyme Q10 restores oocyte mitochondrial function and fertility during reproductive aging. |
2015 |
Aging Cell |
pmid:26111777
|
GazdÃk F et al. |
Decreased levels of coenzyme Q(10) in patients with bronchial asthma. |
2002 |
Allergy |
pmid:12169177
|
Gaby AR |
Nutritional treatments for acute myocardial infarction. |
2010 |
Altern Med Rev |
pmid:20806996
|
Czap A |
A patented double dilemma. |
2004 |
Altern Med Rev |
pmid:15005640
|
Werbach MR |
Nutritional strategies for treating chronic fatigue syndrome. |
2000 |
Altern Med Rev |
pmid:10767667
|
Czap A |
When the shark bites. |
2000 |
Altern Med Rev |
pmid:10696115
|
|
Coenzyme Q10. Monograph. |
2007 |
Altern Med Rev |
pmid:17604461
|
Lamson DW and Plaza SM |
Mitochondrial factors in the pathogenesis of diabetes: a hypothesis for treatment. |
2002 |
Altern Med Rev |
pmid:11991790
|
Daiell R |
Questions about coenzyme Q-10. |
2002 Nov-Dec |
Altern Ther Health Med |
pmid:12440833
|
Liu ZX and Artmann C |
Relative bioavailability comparison of different coenzyme Q10 formulations with a novel delivery system. |
2009 Mar-Apr |
Altern Ther Health Med |
pmid:19284181
|
Sinatra ST |
Metabolic cardiology: the missing link in cardiovascular disease. |
2009 Mar-Apr |
Altern Ther Health Med |
pmid:19284182
|
Mikirova N et al. |
The assessment of the energy metabolism in patients with chronic fatigue syndrome by serum fluorescence emission. |
2012 Jan-Feb |
Altern Ther Health Med |
pmid:22516851
|
Sinatra ST |
Metabolic cardiology: an integrative strategy in the treatment of congestive heart failure. |
2009 May-Jun |
Altern Ther Health Med |
pmid:19472864
|
Jones K et al. |
Coenzyme Q-10 and cardiovascular health. |
2004 Jan-Feb |
Altern Ther Health Med |
pmid:14727496
|
Bragin V et al. |
Integrated treatment approach improves cognitive function in demented and clinically depressed patients. |
2005 Jan-Feb |
Am J Alzheimers Dis Other Demen |
pmid:15751450
|
Hill GJ et al. |
Examining intentions to use CoQ10 amongst breast cancer patients. |
2006 May-Jun |
Am J Health Behav |
pmid:16712445
|
Pepping J |
Coenzyme Q10. |
1999 |
Am J Health Syst Pharm |
pmid:10192685
|
Chagan L et al. |
Use of alternative pharmacotherapy in management of cardiovascular diseases. |
2002 |
Am J Manag Care |
pmid:11924555
|
Hauser RA |
Early pharmacologic treatment in Parkinson's disease. |
2010 |
Am J Manag Care |
pmid:20297870
|
Sacher HL et al. |
The clinical and hemodynamic effects of coenzyme Q10 in congestive cardiomyopathy. |
1997 Feb-Mar |
Am J Ther |
pmid:10423594
|
Harinstein ME et al. |
Normalization of ejection fraction and resolution of symptoms in chronic severe heart failure is possible with modern medical therapy: clinical observations in 11 patients. |
2008 May-Jun |
Am J Ther |
pmid:18496257
|
Bleske BE et al. |
The effect of pravastatin and atorvastatin on coenzyme Q10. |
2001 |
Am. Heart J. |
pmid:11479481
|
Jeejeebhoy F et al. |
Nutritional supplementation with MyoVive repletes essential cardiac myocyte nutrients and reduces left ventricular size in patients with left ventricular dysfunction. |
2002 |
Am. Heart J. |
pmid:12075268
|
Bookstaver DA et al. |
Effect of coenzyme Q10 supplementation on statin-induced myalgias. |
2012 |
Am. J. Cardiol. |
pmid:22608359
|
Silver MA et al. |
Effect of atorvastatin on left ventricular diastolic function and ability of coenzyme Q10 to reverse that dysfunction. |
2004 |
Am. J. Cardiol. |
pmid:15541254
|
Young JM et al. |
Effect of coenzyme Q(10) supplementation on simvastatin-induced myalgia. |
2007 |
Am. J. Cardiol. |
pmid:17950797
|
Molfino A et al. |
Statins, coenzyme Q10, and cachexia: what's the link? |
2007 |
Am. J. Cardiol. |
pmid:17950821
|
Langsjoen PH et al. |
Long-term efficacy and safety of coenzyme Q10 therapy for idiopathic dilated cardiomyopathy. |
1990 |
Am. J. Cardiol. |
pmid:2305693
|
Maurer I et al. |
Coenzyme Q10 and respiratory chain enzyme activities in hypertrophied human left ventricles with aortic valve stenosis. |
1990 |
Am. J. Cardiol. |
pmid:2143625
|
Caso G et al. |
Effect of coenzyme q10 on myopathic symptoms in patients treated with statins. |
2007 |
Am. J. Cardiol. |
pmid:17493470
|
Kamikawa T et al. |
Effects of coenzyme Q10 on exercise tolerance in chronic stable angina pectoris. |
1985 |
Am. J. Cardiol. |
pmid:3927692
|
Chatzizisis YS et al. |
Coenzyme Q10 depletion: etiopathogenic or predisposing factor in statin associated myopathy? |
2008 |
Am. J. Cardiol. |
pmid:18359340
|
Tarry-Adkins JL et al. |
Coenzyme Q10 prevents hepatic fibrosis, inflammation, and oxidative stress in a male rat model of poor maternal nutrition and accelerated postnatal growth. |
2016 |
Am. J. Clin. Nutr. |
pmid:26718412
|
Ravaglia G et al. |
Effect of micronutrient status on natural killer cell immune function in healthy free-living subjects aged >/=90 y. |
2000 |
Am. J. Clin. Nutr. |
pmid:10648276
|
Wang XL et al. |
Cosupplementation with vitamin E and coenzyme Q10 reduces circulating markers of inflammation in baboons. |
2004 |
Am. J. Clin. Nutr. |
pmid:15321805
|
Fotino AD et al. |
Effect of coenzyme Qâ‚â‚€ supplementation on heart failure: a meta-analysis. |
2013 |
Am. J. Clin. Nutr. |
pmid:23221577
|
Priemé H et al. |
No effect of supplementation with vitamin E, ascorbic acid, or coenzyme Q10 on oxidative DNA damage estimated by 8-oxo-7,8-dihydro-2'-deoxyguanosine excretion in smokers. |
1997 |
Am. J. Clin. Nutr. |
pmid:9022536
|
Stocker R and Macdonald P |
The benefit of coenzyme Q10 supplements in the management of chronic heart failure: a long tale of promise in the continued absence of clear evidence. |
2013 |
Am. J. Clin. Nutr. |
pmid:23325068
|
Steele PE et al. |
Clinical laboratory monitoring of coenzyme Q10 use in neurologic and muscular diseases. |
2004 |
Am. J. Clin. Pathol. |
pmid:15298157
|
de Lau LM et al. |
Serum cholesterol levels and the risk of Parkinson's disease. |
2006 |
Am. J. Epidemiol. |
pmid:16905642
|
Yesilova Z et al. |
Systemic markers of lipid peroxidation and antioxidants in patients with nonalcoholic Fatty liver disease. |
2005 |
Am. J. Gastroenterol. |
pmid:15784031
|
Kishita Y et al. |
Intra-mitochondrial Methylation Deficiency Due to Mutations in SLC25A26. |
2015 |
Am. J. Hum. Genet. |
pmid:26522469
|
Quinzii C et al. |
A mutation in para-hydroxybenzoate-polyprenyl transferase (COQ2) causes primary coenzyme Q10 deficiency. |
2006 |
Am. J. Hum. Genet. |
pmid:16400613
|
Mollet J et al. |
CABC1 gene mutations cause ubiquinone deficiency with cerebellar ataxia and seizures. |
2008 |
Am. J. Hum. Genet. |
pmid:18319072
|
Lagier-Tourenne C et al. |
ADCK3, an ancestral kinase, is mutated in a form of recessive ataxia associated with coenzyme Q10 deficiency. |
2008 |
Am. J. Hum. Genet. |
pmid:18319074
|
López LC et al. |
Leigh syndrome with nephropathy and CoQ10 deficiency due to decaprenyl diphosphate synthase subunit 2 (PDSS2) mutations. |
2006 |
Am. J. Hum. Genet. |
pmid:17186472
|
Young JM et al. |
A randomized, double-blind, placebo-controlled crossover study of coenzyme Q10 therapy in hypertensive patients with the metabolic syndrome. |
2012 |
Am. J. Hypertens. |
pmid:22113168
|
Butler MG et al. |
Coenzyme Q10 levels in Prader-Willi syndrome: comparison with obese and non-obese subjects. |
2003 |
Am. J. Med. Genet. A |
pmid:12749057
|
Scaglia F et al. |
Novel homoplasmic mutation in the mitochondrial tRNATyr gene associated with atypical mitochondrial cytopathy presenting with focal segmental glomerulosclerosis. |
2003 |
Am. J. Med. Genet. A |
pmid:14598342
|
Eiholzer U et al. |
Developmental profiles in young children with Prader-Labhart-Willi syndrome: effects of weight and therapy with growth hormone or coenzyme Q10. |
2008 |
Am. J. Med. Genet. A |
pmid:18257095
|
Miller JL et al. |
Carnitine and coenzyme Q10 levels in individuals with Prader-Willi syndrome. |
2011 |
Am. J. Med. Genet. A |
pmid:21337696
|
Kosmas CE et al. |
Statin-mediated low-density lipoprotein lowering in chronic congestive heart failure. |
2014 |
Am. J. Med. Sci. |
pmid:23154655
|
Gorelick C et al. |
Coenzyme Q10 and lipid-related gene induction in HeLa cells. |
2004 |
Am. J. Obstet. Gynecol. |
pmid:15167860
|
Palan PR et al. |
Effects of menstrual cycle and oral contraceptive use on serum levels of lipid-soluble antioxidants. |
2006 |
Am. J. Obstet. Gynecol. |
pmid:16647895
|
Hano O et al. |
Coenzyme Q10 enhances cardiac functional and metabolic recovery and reduces Ca2+ overload during postischemic reperfusion. |
1994 |
Am. J. Physiol. |
pmid:8023979
|
Nakazawa H et al. |
Is superoxide demonstration by electron-spin resonance spectroscopy really superoxide? |
1988 |
Am. J. Physiol. |
pmid:2839995
|
Sheeran FL and Pepe S |
Posttranslational modifications and dysfunction of mitochondrial enzymes in human heart failure. |
2016 |
Am. J. Physiol. Endocrinol. Metab. |
pmid:27406740
|
Maulik N et al. |
Dietary coenzyme Q(10) supplement renders swine hearts resistant to ischemia-reperfusion injury. |
2000 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:10749701
|
Saiki R et al. |
Coenzyme Q10 supplementation rescues renal disease in Pdss2kd/kd mice with mutations in prenyl diphosphate synthase subunit 2. |
2008 |
Am. J. Physiol. Renal Physiol. |
pmid:18784258
|
Gasser DL et al. |
Focal segmental glomerulosclerosis is associated with a PDSS2 haplotype and, independently, with a decreased content of coenzyme Q10. |
2013 |
Am. J. Physiol. Renal Physiol. |
pmid:23926186
|
Palmeira CM et al. |
Enhanced mitochondrial testicular antioxidant capacity in Goto-Kakizaki diabetic rats: role of coenzyme Q. |
2001 |
Am. J. Physiol., Cell Physiol. |
pmid:11502580
|
Buchsbaum R et al. |
Web-based data management for a phase II clinical trial in ALS. |
2009 Oct-Dec |
Amyotroph Lateral Scler |
pmid:19922127
|